InVivoPro

Our ​​continuously expanding portfolio​​ features ​​20+ high-quality monoclonal antibodies (MAbs)​​, each rigorously validated for in vivo applications. These scientifically characterised reagents are ​​immediately available​​ in milligram to multi-gram quantities, supported by ​​UK-based rapid delivery​​ for reliable supply chain continuity.

Key offerings include:
​​· Blocking MAbs​​ targeting epitopes with defined specificity.
​​​​· Functional MAbs​​ and ​​biosimilar controls​​ for mechanistic pharmacology studies ​​​​· Species-specific anti-mouse reagents​​ optimised to eliminate cross-reactivity confounders.

All products undergo ​​three-tier quality assurance​​, ensuring reproducibility in preclinical models. Our ​​iterative development pipeline​​ ensures sustained availability of novel reagents addressing emerging therapeutic targets.